J C Stevenson1, D Crook, I F Godsland
1Wynn Institute for Metabolic Research, London, U.K.
Transdermal hormone replacement therapy (HRT) effectively prevents bone loss and improves cardiovascular risk markers in postmenopausal women. It offers metabolic benefits over oral HRT, particularly for glucose metabolism and triglyceride levels.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: